Life Sciences & Health

Whether it is investing in a lightning-fast quest to develop drugs and vaccines to combat global pandemics, developing cutting-edge technologies to enhance research possibilities or coping with an everchanging regulated environment, the Life Sciences industry is constantly transforming, adapting, and innovating. 

The Life Sciences & Health industries consists of companies operating in the fields of pharmaceuticals, biotechnology, medical devices, biomedical technologies, nutraceuticals, cosmeceuticals, food processing, and others that are dedicated to creating products and solutions to improve the lives of organisms. 

Despite being among the most heavily regulated industries in the world, the Life Sciences industry remains one of the most attractive. The overall market is steadily growing because of increases in the worldwide population, access to medicine in developing countries, ageing populations in developed countries, and, circumstantially, the demands of global pandemics on public health.  

The impact of global health crises

While economic downturns are inevitable, there has been a paradigm shift across the Life Sciences sector, driven by the global pandemic: global R&D collaboration, strategic re-localisation of product development and manufacturing, and specific reactive regulatory facilitation of systemic and coordinated prevention. 

Newly developed processes, used to combat the COVID-19 pandemic, are now being used in the research & development of new drugs and therapeutic products via more efficient clinical trials. Alongside this, the industry has attracted considerable interest and investment in many innovative projects, such as new digitalised processes to improve production performance and smart factories. 

ALTEN: Empowering Innovation in the Life Sciences Industry 

Consequently, the Life Science leaders of tomorrow will be those who adapt to the changes, those with a clear vision, ready to grab new opportunities and face challenges, building up collaboration beyond traditional players, and seeking the best available resources and partners on the market. 

As the European consulting leader in the Life Sciences industry, ALTEN accompanies its clients in developing and manufacturing Life Sciences products focusing on 2 main business lines: 

  • Clinical Research Outsourcing (CRO) services 
  • Life Sciences Manufacturing Operations (LSMO) 

ALTEN in the Life Sciences industry

350 M€

2022 turnover








domains of expertise in Life Sciences: Pharmaceutical Industry, Biotech, Chemicals, Cosmetics, Agrifood, Medical Devices. 

Functional sectors covered by ALTEN

Clinical Research Ops
  • Clinical Operations 
  • Data analytics 
  • Clinical Quality 
  • Vigilance & Medical Information 
  • Regulatory & Market Authorisation 
  • Manufacturing (Production, Packaging) 
  • Supply chain, Logistics, and Purchasing 
  • Manufacturing 4.0 
  • Lean 6/Sigma and continuous improvement 
Engineering and R&D
  • R&D 
  • Tech Transfer, NPI, NPD 
  • Engineering (Maintenance and Commissioning) 
  • Validation (Q&V, CSV, V&V) 
  • Engineering 4.0 
  • PMO, PM 
  • Regulatory Affairs 
  • Quality Assurance 
  • Quality Control 
  • Quality 4.0 


In order to be able to launch large-scale clinical trials (phase 3) of a new vaccine, one of the ten international pharmaceutical industry giants has invested in the construction of a new production site in Belgium. ALTEN has been entrusted with the responsibility of qualifying equipment performance (PQ) and drafting the operating instructions. 

In the context of developing an immunosuppressive drug for post-renal transplant patient, a global leader in generic and biosimilar medicines outsourced the study of the benefits of the pharmacokinetics profile of its product to AIXIAL (specialized subsidiary of ALTEN Group). 

ALTEN has recognized expertise in medical devices and has set up two service centres (Software and Hardware) to support the activities of the R&D centre of one of the world’s leaders in medical imaging. The work carried out by our engineers is in the fields of mammography, interventional radiology, and the development of advanced medical imaging applications. 

The growing use of digital technologies in pharmaceutical industries, in particular, makes CSV (Computer System Validation), which controls the automated production of drugs, necessary. This validation provides the documented proof that a software application or a computer system will operate continuously and will therefore meet predefined GxP (Good Practice) guidelines. 


Pharmaceutical industry 

Pfizer, Abbvie, Sanofi, Johnson & Johnson, Novartis, GSK, Lonza 


Novo Nordisk, Moderna, Thermo Fisher, Gilead, Amgen 




Syngenta, Danone

Medical device industry 

Abbott, Siemens Healthineers, Roche, Becton Dickinson et BioMerieux